For a study, researchers sought to determine if compressive taping was safe in individuals who had seroma as a result of breast cancer surgery. In a public reference hospital in Brazil, the study was a nonrandomized clinical trial of medical equipment used on women who needed seroma aspiration puncture following breast cancer surgery. The intervention consisted of applying compressive tape to the seroma fluctuation region for 5 days and keeping it in place. Dermal alterations produced by tape, subjective symptoms reported throughout the intervention period, and % change in punctured volume before and after the intervention were all evaluated results.

There were 35 women in total (mean age 56.7±12.2 years). The majority of patients had advanced illness stages (≥IIB; 62.9%). Although there was a 28.6% frequency of cutaneous alterations produced by taping, there was an average reduction in aspirated volume of −28.2 mL (95% CI, −48.3 to −8.0; P = .008). Treatment adherence was strong (91.4%), and the majority of patients were satisfied with the treatment (85.7% ). Compressive tape on seroma sites is deemed safe, is well tolerated by patients, and might be utilised as a non-invasive therapy option for seroma that develops following breast cancer surgery. 

Reference:journals.lww.com/aswcjournal/Fulltext/2022/07000/Clinical_Experience_with_Compression_Taping_to.11.aspx